Cohance Lifesciences

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue507.49249.49299.77776.76496.68
Expenses404.39148.81188.55595.38417.54
EBITDA144.58114.44128.72230.96117.30
EBIT113.30102.15113.84172.6077.84
Profit Before Tax103.10100.68111.22165.6071.04
Net Profit75.4576.3383.67122.7752.57
Financial Ratios
Operating Profit Margin29.62%48.48%45.28%28.00%22.58%
Net Profit Margin15.46%32.33%29.43%17.50%12.11%
Earning Per Share (Diluted)1.972.983.263.201.37
Dividends Per Share0.000.000.000.000.00